Applied Genetic Technologies (AGTC) to Offer Common Stock

Applied Genetic Technologies Corporation (Nasdaq: AGTC) announced that it has commenced an underwritten public offering of its common stock. All of the shares in the proposed offering are being sold by AGTC. In addition, AGTC expects to grant to the underwriter a 30-day option to purchase up to an additional 15% of shares of the common stock sold in the public offering. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

You May Also Be Interested In

• Cantor Fitzgerald Upgrades Humana (HUM) to Overweight, 'A Strong 2027 Margin Year Bridges to an Inexpensive 2028 Multiple'
• Rocket Pharmaceuticals (RCKT) Reiterated at Overweight by Cantor Fitzgerald After Update on RP-A501
• Global Capital Meets Frontier Technology at Digital Assets & Tokenization Summit in Singapore